Lloyd C. Trotman

10.5k citations
44 papers · 6.4k indexed · 5 hit papers · h-index 26
Topics
PI3K/AKT/mTOR signaling in cancer (19 papers)Ubiquitin and proteasome pathways (10 papers)Prostate Cancer Treatment and Research (9 papers)

In The Last Decade

Lloyd C. Trotman

41 papers receiving 6.3k citations

Hit Papers

Crucial role of p53-dependent cellular senescence in supp...20032026201020182005200720072004200350010001.5k

Peers

Lloyd C. Trotman
Comparison fields: 5 of 114
  • Molecular Biology 5.2k
  • Oncology 1.4k
  • Cancer Research 1.1k
  • Physiology 870
  • Pulmonary and Respiratory Medicine 813
Replace Akihiro Kurimasa with:
Akihiro Kurimasa Japan
Eugenio Santos Spain
Peter M. Finan United Kingdom
Carla Grandori United States
David T. Weaver United States
Tomohiko Maehama Japan
Kevin M. Haigis United States
Takehiko Kamijo Japan
Shiaw‐Yih Lin United States
Robert Latek United States
Lloyd C. Trotman relative to Akihiro Kurimasa Japan Akihiro Kurimasa's profile →
Citations per field
00.5×1.5×2.1×
Akihiro Kurimasa · 1×
Citations per year

Countries citing papers authored by Lloyd C. Trotman

Since Specialization
Citations

This map shows the geographic impact of Lloyd C. Trotman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd C. Trotman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd C. Trotman more than expected).

Fields of papers citing papers by Lloyd C. Trotman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd C. Trotman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd C. Trotman. The network helps show where Lloyd C. Trotman may publish in the future.

Co-authorship network of co-authors of Lloyd C. Trotman

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd C. Trotman. A scholar is included among the top collaborators of Lloyd C. Trotman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd C. Trotman. Lloyd C. Trotman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 5
5 6
6 58
7 15
8 133
9 15
10 64
11 12
12 68
13 31
14 7
15 69
16 55
17 131
18
Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppressionbreakdown →
593
19
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTENbreakdown →
576
20
SUMO Modification of Huntingtin and Huntington's Disease Pathologybreakdown →
547

About Lloyd C. Trotman

Lloyd C. Trotman is a scholar working on Molecular Biology, Cancer Research and Toxicology, having authored 44 papers that have together received 6.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (19 papers), Ubiquitin and proteasome pathways (10 papers) and Prostate Cancer Treatment and Research (9 papers). The work is most often cited by research in Molecular Biology (5.2k citations), Cancer Research (1.1k citations) and Aging (119 citations). Lloyd C. Trotman has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Pier Paolo Pandolfi, Carlos Cordon‐Cardo, Zhenbang Chen, Jason A. Koutcher, Andrea Alimonti, Zohar Dotan, Masaru Niki, Howard I. Scher, William L. Gerald and David R. Shaffer. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026